Clinical Going Global: Why Australia and Europe Matter More for Chinese Biotech

Yihang Chen 6/16/26 Yihang Chen 6/16/26

Clinical Going Global: Why Australia and Europe Matter More for Chinese Biotech

Read More

Recommended Chinese CDMO and CRO Resources for RNA and Nucleic-Acid Development

Yihang Chen 6/14/26 Yihang Chen 6/14/26

Recommended Chinese CDMO and CRO Resources for RNA and Nucleic-Acid Development

Read More

Candid Therapeutics and UCB: When China-Origin Assets Become Global Strategy

Yihang Chen 5/5/25 Yihang Chen 5/5/25

Candid Therapeutics and UCB: When China-Origin Assets Become Global Strategy

Read More

Why China’s Clinical Development Ecosystem Is Becoming Harder to Ignore

Yihang Chen 4/20/25 Yihang Chen 4/20/25

Why China’s Clinical Development Ecosystem Is Becoming Harder to Ignore

Read More